tradmap

YCBD Financials cbdMD, Inc.

10 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 14.5% per year over the past 5 years.
  • Operating margin has expanded, at -11.3% in the latest year.

Financial health

  • Total debt has grown slower than revenue (-96.8% vs -14.5% per year).
  • The company is unprofitable; at its current free-cash-flow burn it has roughly 1.4 years of cash runway.
Revenue & net income
-$70M -$13M $44M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
RevenueNet income
Margins (gross / operating / net)
-391% -157% 77% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-1072% -528% 16% 0% 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
ROEROA
Free cash flow (CFO − capex)
-$16M -$8M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $13M $26M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$15M $6M $28M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $19M -$2M 62.4% -11.3% -28.2% -19.6% -$2M $2M
2024 $19M -$4M 61.6% -17.0% -188.5% -35.0% -$542807 $2M
2023 $24M -$23M 62.0% -93.1% -254.0% -141.6% -$5M $9 $2M
2022 $35M -$70M 63.1% -221.1% -223.0% -171.8% -$16M $125491 $7M
2021 $44M -$23M 67.4% -44.1% -22.7% -18.7% -$14M $108985 $26M
2020 $42M $13M 63.0% -42.0% 15.9% 11.4% $264367 $15M
2019 $24M -$51M 61.4% -62.6% -136.6% -54.3% $5M
2018 $459091 $62834 77.3% -391.4% 0.4% 0.4% $4M
2017 $4M -$1M 69.7% -30.4% -32.9% -19.6% $284246
2016 $2M -$4M 20.3% -191.4% -1072.1% -240.0% $34258

Valuation over time

How the market has priced YCBD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / sales (P/S)
0.0 4.1 8.3 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is YCBD growing its revenue and profit?

Over the past 5 years, cbdMD, Inc.'s revenue has declined 14.5% per year. These are computed facts, not advice.

How much debt does YCBD have?

As of FY2025, cbdMD, Inc. reported — of total debt against $2M of cash.

What is YCBD's profit margin?

In FY2025, gross margin was 62.4%, operating margin -11.3%, and net margin -10.6%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.